{"id":3988,"date":"2014-09-21T11:06:00","date_gmt":"2014-09-21T11:06:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=3988"},"modified":"2022-04-13T12:31:08","modified_gmt":"2022-04-13T12:31:08","slug":"first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/","title":{"rendered":"First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis."},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Saniabadi+AR&amp;cauthor_id=25110409\"><\/a><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ihara+S&amp;cauthor_id=25015850\">S Ihara<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yamaji+Y&amp;cauthor_id=25015850\">Y Yamaji<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-2\">2<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kinoshita+H&amp;cauthor_id=25015850\">H Kinoshita<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yamada+A&amp;cauthor_id=25015850\">A Yamada<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hirata+Y&amp;cauthor_id=25015850\">Y Hirata<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Hasegawa+K&amp;cauthor_id=25015850\">K Hasegawa<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Sugawara+Y&amp;cauthor_id=25015850\">Y Sugawara<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kokudo+N&amp;cauthor_id=25015850\">N Kokudo<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Koike+K&amp;cauthor_id=25015850\">K Koike<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/#affiliation-1\">1<\/a><\/sup><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Transplant Proc <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=%22Transplant+Proc%22%5Bjour%5D\"><\/a>2014 Sep;46(7):2414-7.&nbsp;doi: 10.1016\/j.transproceed.2014.02.016.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Background:&nbsp;<\/strong>Immunosuppressants such as tacrolimus and cyclosporine are prescribed long-term after orthotopic liver transplantation (OLT) to prevent allograft rejection. Although these immunosuppressants are known to effectively control ulcerative colitis (UC), some post-OLT patients develop exacerbation of preexisting UC or de novo UC. Although aminosalicylates and corticosteroid courses are usually effective to treat such UC, several patients have developed uncontrollable disease and required colectomies. <strong>Case report:&nbsp;<\/strong>We have reported a patient who developed de novo UC after OLT to treat liver cirrhosis and hepatocellular carcinoma associated with hepatitis B virus (HBV) infection. Existence of the HBV infection made us avoid to increase the corticosteroid dose or to use other immunosuppressants such as azathioprine or infliximab. <strong>Conclusions:&nbsp;<\/strong>In this patient, granulocyte and monocyte apheresis was highly effective in terms of inducing remission of de novo UC. No adverse event was noted.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25015850\/<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>S Ihara&nbsp;1,&nbsp;Y Yamaji&nbsp;2,&nbsp;H Kinoshita&nbsp;1,&nbsp;A Yamada&nbsp;1,&nbsp;Y Hirata&nbsp;1,&nbsp;K Hasegawa&nbsp;3,&nbsp;Y Sugawara&nbsp;3,&nbsp;N Kokudo&nbsp;3,&nbsp;K Koike&nbsp;1 Transplant Proc 2014 Sep;46(7):2414-7.&nbsp;doi: 10.1016\/j.transproceed.2014.02.016. Background:&nbsp;Immunosuppressants such as tacrolimus and cyclosporine are prescribed long-term after orthotopic liver transplantation (OLT) to prevent allograft rejection. Although these immunosuppressants are known to effectively control ulcerative colitis (UC), some post-OLT patients develop exacerbation of preexisting UC or de novo [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[276,595,157,424,145,630,148,216,156,306],"class_list":["post-3988","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-cases","scientific_tags-complete-clinical-remission","scientific_tags-efficacy","scientific_tags-gma","scientific_tags-hepatitis-b","scientific_tags-liver-transplantation","scientific_tags-long-term-efficacy","scientific_tags-rapid-efficay","scientific_tags-safety","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"S Ihara&nbsp;1,&nbsp;Y Yamaji&nbsp;2,&nbsp;H Kinoshita&nbsp;1,&nbsp;A Yamada&nbsp;1,&nbsp;Y Hirata&nbsp;1,&nbsp;K Hasegawa&nbsp;3,&nbsp;Y Sugawara&nbsp;3,&nbsp;N Kokudo&nbsp;3,&nbsp;K Koike&nbsp;1 Transplant Proc 2014 Sep;46(7):2414-7.&nbsp;doi: 10.1016\/j.transproceed.2014.02.016. Background:&nbsp;Immunosuppressants such as tacrolimus and cyclosporine are prescribed long-term after orthotopic liver transplantation (OLT) to prevent allograft rejection. Although these immunosuppressants are known to effectively control ulcerative colitis (UC), some post-OLT patients develop exacerbation of preexisting UC or de novo [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-13T12:31:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/\",\"name\":\"First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2014-09-21T11:06:00+00:00\",\"dateModified\":\"2022-04-13T12:31:08+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/","og_locale":"es_ES","og_type":"article","og_title":"First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis. - Adacyte","og_description":"S Ihara&nbsp;1,&nbsp;Y Yamaji&nbsp;2,&nbsp;H Kinoshita&nbsp;1,&nbsp;A Yamada&nbsp;1,&nbsp;Y Hirata&nbsp;1,&nbsp;K Hasegawa&nbsp;3,&nbsp;Y Sugawara&nbsp;3,&nbsp;N Kokudo&nbsp;3,&nbsp;K Koike&nbsp;1 Transplant Proc 2014 Sep;46(7):2414-7.&nbsp;doi: 10.1016\/j.transproceed.2014.02.016. Background:&nbsp;Immunosuppressants such as tacrolimus and cyclosporine are prescribed long-term after orthotopic liver transplantation (OLT) to prevent allograft rejection. Although these immunosuppressants are known to effectively control ulcerative colitis (UC), some post-OLT patients develop exacerbation of preexisting UC or de novo [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/","og_site_name":"Adacyte","article_modified_time":"2022-04-13T12:31:08+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/","name":"First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2014-09-21T11:06:00+00:00","dateModified":"2022-04-13T12:31:08+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/first-case-report-of-de-novo-ulcerative-colitis-developing-after-orthotopic-liver-transplantation-successfully-treated-by-granulocyte-and-monocyte-apheresis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/3988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=3988"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=3988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}